Vycor Medical (VYCO) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.88% |
| Dec 31, 2025 | 3.51% |
| Dec 31, 2024 | 14.93% |
| Sep 30, 2024 | 14.30% |
| Mar 31, 2024 | 16.05% |
| Dec 31, 2023 | 3.12% |
| Sep 30, 2023 | 9.34% |
| Jun 30, 2023 | 14.95% |
| Mar 31, 2023 | 15.12% |
| Dec 31, 2022 | 15.03% |
| Sep 30, 2022 | 14.89% |
| Dec 31, 2021 | 14.99% |
| Sep 30, 2021 | 4.30% |
| Jun 30, 2021 | -22.12% |
| Mar 31, 2021 | -6.87% |
| Dec 31, 2020 | 58.86% |
| Sep 30, 2020 | 64.80% |
| Jun 30, 2020 | 23.23% |
| Mar 31, 2020 | 10.29% |
| Sep 30, 2019 | 28.84% |
| Jun 30, 2019 | 46.25% |
| Mar 31, 2019 | 31.06% |
| Dec 31, 2018 | 28.58% |
| Sep 30, 2018 | 42.34% |
| Jun 30, 2018 | 14.07% |
| Mar 31, 2018 | 37.54% |
| Dec 31, 2017 | -28.69% |
| Sep 30, 2017 | -11.06% |
| Jun 30, 2017 | 10.71% |
| Mar 31, 2017 | 14.70% |
| Dec 31, 2016 | 20.70% |
| Sep 30, 2016 | -3.39% |
| Jun 30, 2016 | 46.03% |
| Mar 31, 2016 | -13.70% |
| Dec 31, 2015 | 29.30% |
| Sep 30, 2015 | -41.79% |